This study also demonstrated that the accumulation of 2-hydroxyglutarate (2HG), a metabolite produced by mutant IDH, was linked to seizure occurrence, suggesting that metabolic dysregulation may contribute to glioma-related epileptogenesis (6, 7). This evidence concerns the gene IDH1 and central nervous system cancer.